摘要
卵巢癌是死亡率最高的妇科恶性肿瘤。由于腹腔镜具有创伤小、术后恢复快的优点,已有研究者尝试将腹腔镜引入卵巢癌的诊疗中。由于目前缺少充分的循证医学证据,在对卵巢进行诊疗时,腹腔镜的使用范围应限于两类人群:①部分Ⅰ期患者;②无法直接接受手术需要进行新辅助化学治疗的Ⅲ～Ⅳ期患者的活组织检查。需要注意的是并非所有术前分期为Ⅰ期的患者都适合接受腹腔镜,而肿瘤破裂、穿刺孔种植都会对患者的预后造成不良影响。
Ovarian cancer is one of the highest mortality gynecological malignancies. Since laparo- scopic surgery with fewer traumas, faster postoperative recovery advantages, it has been introduced to the diag- nosis and treatment of ovarian cancer by some researchers. Given a paucity of appropriate evidence, laparo- scopic surgery should be restricted to two populations： （1） selected patients with stage I disease; （2） inoperable patients with suspected stage II[ or IV disease who is candidate for neo-adjuvant chemotherapy. It is noted that laparoseopic operation is not suitable for all patients with suspected stage I ovarian cancer. Furthermore, the tumor rupture and puncture of planting will adversely affect the prognosis of patients.
出处
《新医学》
2013年第8期519-521,共3页
Journal of New Medicine
关键词
腹腔镜
卵巢癌
肿瘤分期
新辅助化学治疗
Laparoscopic surgery
Ovarian cancer
Tumor staging
Neo-adjuvant chemotherapy
